Sorafenib in Newly Diagnosed High Grade Glioma
Conditions
- Glioblastoma
- Gliosarcoma
- Anaplastic Astrocytoma
- Anaplastic Oligoastrocytoma
- Anaplastic Oligodendroglioma
Interventions
- DRUG: Sorafenib dose escalation
Sponsor
University Hospital, Geneva
Collaborators